Structure |
Chemical Name |
CAS |
MF |
|
EMpagliflozin iMpurity 10 |
2069942-68-1 |
C32H37ClO12 |
|
EMpagliflozin iMpurity 15 |
|
|
|
(S)-8-(3-aMinopiperidin-1-yl)-7-(but-2-ynyl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione |
668269-51-0 |
C25H28N8O2 |
|
ibrutinib iMpurity B |
|
|
|
Sunitinib iMpurity A |
|
|
|
Sunitinib iMpurity F |
|
|
|
(3R,4S)-1-(3-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1700622-06-5 |
C24H21F2NO3 |
|
Betamethasone EP Impurity J |
18383-24-9 |
C22H30O4 |
|
Cefazedone Related Impurity 10 |
18884-65-6 |
C10H12N2O5S |
|
Etoricoxib Impurity 8 |
1421227-97-5 |
C22H20N2O4S |
|
Mupirocin Impurity E |
|
C26H44O9 |
|
Phenylephrine Impurity 1 |
|
C9H13NO2 |
|
Rupatadine Impurity B |
156523-04-5 |
C26H24ClN3O |
|
Theophylline Impurity 1 |
5614-53-9 |
C9H10N4O3 |
|
Venlafaxine N-Dimer |
1187545-61-4 |
C32H48N2O4 |
|
Rosuvastatin Impurity 105 |
|
|
|
ent-Ivabradine Hydrochloride |
148849-68-7 |
C27H37ClN2O5 |
|
(2R,3R,4R,5S,6R)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
1620758-27-1 |
C31H35ClO11 |
|
Febuxostat Impurity 99 |
|
|
|
Furosemide Impurity 20 |
|
|
|
1-((2S,3S)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-((methyl(3-((2-(methylamino)acetoxy)methyl)pyridin-2-yl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium |
|
|
|
(3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate |
1191921-01-3 |
C18H30N2O5 |
|
Ticagrelor Impurity 109 |
|
|
|
Ticagrelor Impurity 134 |
|
|
|
Relugolix Impurity 66 |
2591260-06-7 |
C25H24F2N2O6S |
|
methyl 3-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)-3- oxopropanoate |
|
|
|
methyl 5-methyl-3'-nitro-3-oxo-1,2,3,6-tetrahydro-[1,1'-biphenyl]-2-carboxylate |
2469735-68-8 |
C15H15NO5 |
|
Pregn-4-ene-3,20-dione, 9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11β,16α)- |
3093-36-5 |
C24H33FO5 |
|
INDEX NAME NOT YET ASSIGNED |
2402776-84-3 |
C23H27N9O4S2 |
|
Sofosbuvir metabolites GS566500 |
1233335-78-8 |
C13H19FN3O9P |
|
Ondansetron impurity G (PhEur) |
99614-04-7 |
C17H18ClN3O |
|
4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid methyl ester |
1421312-34-6 |
C18H15NO4 |
|
2-[(4-メチルフェノキシ)メチル]安息香酸 |
728-97-2 |
C15H14O3 |
|
Ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3- (1-ethylpropoxy)cyclohexanecarboxylate |
2124269-41-4 |
C16H29N5O4 |
|
2-AMINO-3,5-DIBROMOBENZENE-1-CARBOHYDRAZIDE |
97096-13-4 |
C7H7Br2N3O |
|
N-トリチルロサルタン |
133909-99-6 |
C41H37ClN6O |
|
4'-(ブロモメチル)-[1,1'-ビフェニル]-2-カルボン酸 |
150766-86-2 |
C14H11BrO2 |
|
Letrozole Impurity |
|
|
|
Parecoxib Impurity J |
|
|
|
6-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(2-oxo-1,2-dihydroquinolin-7-yloxy)butyl)quinolin-2(1H)-one |
|
C38H40N4O4S |
|
Linagliptin Impurity J |
|
|
|
Linagliptin Impurity Q |
|
|
|
(R)-2-(((1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)amino)methyl)-4-fluorobenzonitrile |
|
C26H24F2N6O2 |
|
Rosuvastatin Calcium Impurity |
|
|
|
Piperazine, 1-methyl-4-[(4-methyl-1-piperazinyl)carbonyl]- |
4180-30-7 |
C11H22N4O |
|
Cefdinan impurity S |
|
|
|
(4S)-2-(((R)-2-Amino-2-phenylacetamido)(carboxy)-methyl)-5,5-dimethylthiazolidine-4-carboxylic |
1642629-93-3 |
C16H21N3O5S |
|
3,3'-(ethane-1,2-diyl)bis(1-(2-chloroethyl)-1H-benzo[d]imidazol-2(3H)-one) |
191977-79-4 |
C20H20Cl2N4O2 |
|
octakis(6-chloro-6-deoxy)-γ-cyclodextrin |
173094-60-5 |
C48H72Cl8O32 |
|
N-[4-(difluoromethoxy)-2-nitrophenyl]acetamide |
97963-75-2 |
C9H8F2N2O4 |
|
Ropivacaine-ET |
2180-94-1 |
C16H24N2O |
|
Pitavastatin Dihydrobenzophenanthridine |
1187966-91-1 |
C25H24FNO4 |
|
BDJS-SH 3 |
1817657-89-8 |
C12H18N2O2 |
|
Blonanserin impurity E |
|
|
|
Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[(aminocarbonyl)amino]-2-hydroxy-, (1S,2S,3R,4R)- |
2597901-48-7 |
C15H27N3O5 |
|
3-Isoquinolinecarboxylic acid, 7-(4-chlorophenoxy)-4-hydroxy-, methyl ester |
2711953-58-9 |
C17H12ClNO4 |
|
(2-(2-((tert-butoxycarbonyl)(methyl)amino)-N-methylacetamido)pyridin-3-yl)methyl N-(tert-butoxycarbonyl)-N-methylglycinate |
|
|
|
Benzoic acid, 3-(aminosulfonyl)-2,4-dichloro- |
1870323-25-3 |
C7H5Cl2NO4S |
|
Benzeneacetamide, N,α,α-trimethyl-N-[6-(4-methyl-1,4-dioxido-1-piperazinyl)-4-(2-methylphenyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)- |
1431216-61-3 |
C30H32F6N4O3 |
|
Tafluprost Impurity 15 |
|
|
|
Rosuvastatin Impurity 159 (Sodium salt) |
|
|
|
Rosuvastatin Impurity 140 |
|
|
|
Rosuvastatin Impurity 130 |
|
|
|
Clindamycin Impurity 17 |
|
|
|
Edaravone Impurity 12 |
2061958-41-4 |
C12H16N2O2 |
|
Empagliflozin Impurity 19 |
|
|
|
Erythromycin impurity D |
|
|
|
FeBuxostat Impurity 40 |
|
|
|
Formoterol Impurity 13 |
150513-24-9 |
C18H24N2O3 |
|
Fosaprepitant Impurity 4 |
1523569-85-8 |
C37H34F7N4O6P |
|
Fudosteine Impurity 2 |
1480319-53-6 |
C6H13NO5S |
|
Isavuconazole Impurity 10 |
|
|
|
Isavuconazole Impurity 18 |
|
|
|
Isavuconazole Impurity 6 |
|
|
|
Lercanidipine Impurity 4 |
2727061-30-3 |
C18H23NO2 |
|
Nitrendipine Impurity 4 |
|
|
|
Olaparib Impurity 6 |
|
|
|
Paclitaxel EP Impurity H |
|
|
|
Paroxetine Impurity 10 |
|
|
|
Posaconazole Impurity 31 |
|
|
|
Posaconazole Impurity 60 |
2134652-05-2 |
C14H14F2O4 |
|
Regorafenib impurity D |
|
|
|
SofosBuvir impurity 21 |
1496552-50-1 |
C22H29ClN3O9P |
|
sofosBuvir impurity 36 |
|
|
|
SofosBuvir Impurity 52 |
|
|
|
SofosBuvir Impurity 59 |
|
|
|
Ticagrelor impurity 25 |
|
|
|
Tirofiban Impurity 14 |
1103300-75-9 |
C12H17NO5S |
|
Tirofiban Impurity 19 |
158808-75-4 |
C18H28N2O3 |
|
Ampicillin Impurity S |
|
|
|
Cefdinir Impurity F (CP) |
|
|
|
Flucloxacillin Sodium Impurity A |
68728-50-7 |
C19H20ClFN3NaO6S |
|
Oxacillin Sodium Impurity G(EP) |
724695-30-1 |
C19H18ClN3O5S |
|
Spectinomycin Impurity D |
|
|
|
(4R,4aS,5aR,12aS)-9-[2-(tert-butylamino)acetamido]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide |
|
C29H39N5O8 |
|
Amifostine Impurity 3 |
41510-53-6 |
C5H15N2O3PS |
|
Cefradine impurity C |
|
|
|
Cefuroxime sodium impurity H |
|
C16H16N4NaO8S |
|
Bilastine N-Oxide |
2069238-47-5 |
C28H37N3O4 |
|
Cefoxitin impurity F |
|
|